Dupilumab-Associated Blepharoconjunctivitis with Giant Papillae

PURPOSE: To describe a case of severe dupilumab-associated blepharoconjunctivitis with giant papillae treated with high potency corticosteroid eyedrops, without discontinuing or reducing dupilumab therapy. CASE REPORT: A 22-year-old Latin American female with a long history of severe atopic dermatit...

Descripción completa

Detalles Bibliográficos
Autores principales: Vingopoulos, Filippos, Lazzaro, Douglas R
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7410394/
https://www.ncbi.nlm.nih.gov/pubmed/32801940
http://dx.doi.org/10.2147/IMCRJ.S263068

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7410394/
https://www.ncbi.nlm.nih.gov/pubmed/32801940
http://dx.doi.org/10.2147/IMCRJ.S263068

Ejemplares similares